Literature DB >> 22608676

When the timing is right: Antibiotic timing and infection after cardiac surgery.

Colleen G Koch1, Edward R Nowicki, Jeevanantham Rajeswaran, Steven M Gordon, Joseph F Sabik, Eugene H Blackstone.   

Abstract

OBJECTIVES: Guidelines recommend antibiotic prophylaxis 60 minutes before skin incision; however, it is unclear whether more precise timing would further reduce sternal wound infection. Our objectives were to examine the relationship between antibiotic timing and infection, test potential efficacy of optimal antibiotic timing in preventing infection, and determine whether patient comorbidity is related to timing and infection.
METHODS: From 1/1/1995-1/1/2008, 28,250 patients underwent 28,702 cardiac surgical procedures involving a median sternotomy; 85% received only cefuroxime and 15% received only vancomycin prophylaxis. Multivariable analysis identified factors associated with infection within each phase, and risk-adjusted optimal timing was determined using patient data, risk variables, and hypothetical values of antibiotic timing.
RESULTS: Prevalence of sternal wound infection was 2.0% (489 patients) for cefuroxime and 2.3% (101 patients) for vancomycin. Minimum prevalence for infection was 1.8% observed when cefuroxime was administered 15 minutes before incision; risk increased to 2.2% with administration more than 45 minutes before incision and to 2.8% at 60 minutes before incision. Minimum prevalence of infection in patients who received vancomycin was 1.8% observed with initiation 32 minutes before incision; risk increased to 2.2% for administration 45 minutes before incision and 3.2% with administration 60 minutes before incision. Simulation for optimal timing found that it was influenced by phase-specific risk factors.
CONCLUSIONS: Refining current antibiotic prophylaxis guidelines may lower sternal wound infections. Antibiotic administration timing resulting in lowest likelihood for infection varied with antibiotic and patient-specific factors. Optimal risk-adjusted timing could potentially reduce infections by 9%-31%.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608676     DOI: 10.1016/j.jtcvs.2012.01.087

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland.

Authors:  James Kofi Ackah; Louise Neal; Neil R Marshall; Pedram Panahi; Clinton Lloyd; Luke J Rogers
Journal:  J Infect Prev       Date:  2020-11-24

2.  Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty.

Authors:  Katharine D Harper; Bradley S Lambert; James O'Dowd; Thomas Sullivan; Stephen J Incavo
Journal:  Arthroplast Today       Date:  2020-03-07

3.  Questionnaire Survey Regarding Prevention of Surgical Site Infection after Neurosurgery in Japan: Focus on Perioperative Management and Administration of Surgical Antibiotic Prophylaxis.

Authors:  Shingo Matsuda; Fusao Ikawa; Hideo Ohba; Michitsura Yoshiyama; Toshikazu Hidaka; Kaoru Kurisu; Susumu Miyamoto; Isao Date; Hiroyuki Nakase
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-05-09       Impact factor: 1.742

4.  Causal Analysis of World Health Organization's Surgical Safety Checklist Implementation Quality and Impact on Care Processes and Patient Outcomes: Secondary Analysis From a Large Stepped Wedge Cluster Randomized Controlled Trial in Norway.

Authors:  Arvid Steinar Haugen; Hilde Valen Wæhle; Stian Kreken Almeland; Stig Harthug; Nick Sevdalis; Geir Egil Eide; Monica Wammen Nortvedt; Ingrid Smith; Eirik Søfteland
Journal:  Ann Surg       Date:  2019-02       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.